Literature DB >> 11791750

Brief note and evaluation of acute-radiation syndrome and treatment of a Tokai-mura criticality accident patient.

T Ishii1, S Futami, M Nishida, T Suzuki, T Sakamoto, N Suzuki, K Maekawa.   

Abstract

Patient A who was exposed to a critical dose of radiation developed skin lesions throughout the body surface, gastrointestinal disorder with massive diarrhea and prominent bleeding, which caused severe loss in body fluids. Gastrointestinal bleeding due to the deteriorated intestinal mucosa was considered to be one of the major causes of death, although infection did not develop, possibly because of SDD and aseptic intensive care, until terminal stages. Patient A ultimately developed respiratory and renal failure in addition to skin exudate and gastrointestinal bleeding, and died of multiple organ failure on the 83rd day after exposure. The extreme unevenness of the dose distribution and the neutron versus y-ray component made the clinical manifestation very complicated. Initially, the mean absorbed dose was calculated as 16-20 GyEq for Patient A, mainly based on neutron-activated 24Na in the blood. However, a very recent calculation showed that the absorbed skin dose was highest at the upper-right abdomen reaching 61.8 Gy (27.0 as neutron plus 34.8 Gy as y-ray). The dorsal side was calculated to have received one eighth of the value of the abdominal side, and much smaller neutron component. His absorbed-dose distribution throughout the body was very inhomogeneous because of the closeness of the standing point to the mixing tank. Despite prolonged survival because of intensive care with massive fluids and blood transfusion, peripheral blood stem-cell transplantation, cultured skin-cell grafts, and the administration of cytokines for marrow, the patient was not saved. Restoration of the bone marrow function, prevention of skin fibrosis, radiation lung damage, and repair of gastrointestinal mucosa, and final recovery of the patient were elusive. Abundant personnel and resources were also a prerequisite to allow for the comprehensive and collective intensive care. A further understanding of the effects of high-dose radiation as well as the basic and clinical development of regeneration medicine are important issues for the future.

Entities:  

Mesh:

Year:  2001        PMID: 11791750     DOI: 10.1269/jrr.42.s167

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  14 in total

1.  Interleukin-12 preserves the cutaneous physical and immunological barrier after radiation exposure.

Authors:  Scott A Gerber; Ryan J Cummings; Jennifer L Judge; Margaret L Barlow; Julee Nanduri; Doug E Milano Johnson; James Palis; Alice P Pentland; Edith M Lord; Julie L Ryan
Journal:  Radiat Res       Date:  2015-01-07       Impact factor: 2.841

Review 2.  Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems.

Authors:  Nicholas Dainiak; Robert Nicolas Gent; Zhanat Carr; Rita Schneider; Judith Bader; Elena Buglova; Nelson Chao; C Norman Coleman; Arnold Ganser; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Viktor Meineke
Journal:  Disaster Med Public Health Prep       Date:  2011-10-10       Impact factor: 1.385

Review 3.  A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.

Authors:  Mohamad B Dabjan; Carolyn Ms Buck; Isabel L Jackson; Zeljko Vujaskovic; Brian Marples; Julian D Down
Journal:  Lab Invest       Date:  2016-08-01       Impact factor: 5.662

4.  Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation.

Authors:  Lurong Zhang; Weimin Sun; Jianjun Wang; Mei Zhang; Shanmin Yang; Yeping Tian; Sadasivan Vidyasagar; Louis A Peña; Kunzhong Zhang; Yongbing Cao; Liangjie Yin; Wei Wang; Lei Zhang; Katherine L Schaefer; Lawrence J Saubermann; Steven G Swarts; Bruce M Fenton; Peter C Keng; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-01       Impact factor: 7.038

Review 5.  Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation.

Authors:  Andrea L DiCarlo; Carmen Maher; John L Hick; Dan Hanfling; Nicholas Dainiak; Nelson Chao; Judith L Bader; C Norman Coleman; David M Weinstock
Journal:  Disaster Med Public Health Prep       Date:  2011-03       Impact factor: 1.385

6.  Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation.

Authors:  Regina M Day; Michal Barshishat-Kupper; Steven R Mog; Elizabeth A McCart; P G S Prasanna; Thomas A Davis; Michael R Landauer
Journal:  J Radiat Res       Date:  2008-04-23       Impact factor: 2.724

7.  Do variations in mast cell hyperplasia account for differences in radiation-induced lung injury among different mouse strains, rats and nonhuman primates?

Authors:  Julian D Down; Meetha Medhora; Isabel L Jackson; J Mark Cline; Zeljko Vujaskovic
Journal:  Radiat Res       Date:  2013-07-02       Impact factor: 2.841

Review 8.  Ghrelin as a novel therapy for radiation combined injury.

Authors:  Asha Jacob; Kavin G Shah; Rongqian Wu; Ping Wang
Journal:  Mol Med       Date:  2010-01-19       Impact factor: 6.354

9.  Case review of severe acute radiation syndrome from whole body exposure: concepts of radiation-induced multi-organ dysfunction and failure.

Authors:  Koichi Tanigawa
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 10.  Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.

Authors:  Vijay K Singh; Patricia L P Romaine; Thomas M Seed
Journal:  Health Phys       Date:  2015-06       Impact factor: 1.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.